Study of Licarbazepine in the Treatment of Manic Episodes of Bipolar Disorder

NCT00107939 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

453

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Licarbazepine

Sponsor

Novartis Pharmaceuticals